I am currently a Postdoctoral Fellow at the Wellcome Trust Sanger Institute, Cambridge, UK as part of their new Synthetic Genomics Group.
Previously, I was based at the Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria. Working in the lab of Prof. Florian Grebien, I studied the interactome of leukaemia-associated fusion oncogenes through mass spectrometry and CRISPR/Cas9. I completed my undergraduate degree in Genetics at Queen’s University Belfast in Northern Ireland. After a short, but incredibly useful, spell in industry I began a PhD at the Centre for Cancer Research and Cell Biology in Belfast. In the lab of Prof. Ken Mills, I worked on understanding the transcriptional changes involved in myelodysplastic syndrome development and progression to leukaemia. My first Postdoc there developed and investigated genetic models of SF3B1 gene mutation using CRISPR/Cas9.
Whether applicable to my own research in understanding human disease or to basic biology, my passion lies in learning about new additions to the increasingly powerful molecular toolbox.